The 8th Conference on the Molecular Biology of Hearing & Deafness

描述（由申请人提供）：部分支持是听力和耳聋的分子生物学会议（MBHD）的要求。这一系列会议自1992年以来成功地举行，有力地证明今后的会议将继续取得成功。第八届会议将在英国剑桥附近的欣克斯顿桑格研究所的欢迎信托会议中心举行，2011年7月6日至9日。对这次会议的支持将用于减少美国学生/博士后研究员和代表性不足的少数民族科学家的出席费用，因为现有的对此类旅行的支持仅限于英国。欧洲候选人。还请求为将于2013年10月在加利福尼亚州拉霍亚举行的第9次会议和将在联合王国举行的第10次会议提供支持。2015年具体目标1.促进分子生物学新兴领域的研究。目前这些措施包括：大规模并行的下一代测序;表观遗传学;和比较基因组学;由于技术进步和积累的序列数据，这些技术最近经历了显著的增长。2.回顾与听力和耳聋相关的分子生物学进展，邀请参与近期重要研究的科学家介绍他们的研究结果，并征集报告与听觉系统相关的分子水平研究的免费论文。3.促进从事分子听觉研究的不同实验室之间的互动和合作，以及基础科学家和临床医生之间对耳聋的分子生物学和分子遗传学的相关兴趣。4.促进转化型研究，以开发听力障碍的诊断和治疗方法。5.鼓励来自代表性不足的少数群体的受训人员和科学家从事听力和耳聋分子生物学方面的职业。6.为当地的患者、患者倡导团体、临床医生和学校提供外展服务，以进行耳聋遗传学和听力研究方面的教育。

DESCRIPTION (provided by applicant): Partial support is requested for Conferences on the Molecular Biology of Hearing and Deafness (MBHD). This series of meetings has been held successfully since 1992, which argues strongly for the continued success of the future Conferences. The 8th Conference will occur at the Welcome Trust Conference Center at the Sanger Institute in Hinxton, near Cambridge, U.K., on July 6-9, 2011. Support for this conference would be used to reduce the cost of attendance for U.S. students/ postdoctoral fellows and under-represented minority scientists, since existing support for such travel is restricted to U.K. and European candidates. Support is also requested for the 9th Conference, to be held in La Jolla, CA in October of 2013, and the 10th Conference, to be held in the U.K. in 2015. Specific Aims 1. To promote research in emerging areas of molecular biology. These currently include: massively parallel, next-generation sequencing; epigenetics; and comparative genomics; which have experienced significant recent growth due to technical advances and accumulating sequence data. 2. To review progress in molecular biology related to hearing and deafness by inviting scientists involved in significant recent research to present their results, and by soliciting free papers reporting research at the molecular level related to the auditory system. 3. To facilitate interaction and collaboration between different laboratories engaged in molecular auditory research, as well as between basic scientists and clinicians with related interests in the molecular biology and molecular genetics of deafness. 4. To promote translational research that can lead to diagnostics and therapeutics for the treatment of hearing disorders. 5. To encourage trainees and scientists from under-represented minorities to enter careers in the molecular biology of hearing and deafness. 6. To provide outreach to patients, patient advocacy groups, clinicians and schools in the local area, for education in the genetics of deafness and hearing research.